Desoxyn Side Effects, and Drug Interactions - Methamphetamine

Desoxyn Side Effects, and Drug Interactions - Methamphetamine

SIDE EFFECTS

The following are adverse reactions in decreasing order of severity within each category that have been reported:

Cardiovascular:   Elevation of blood pressure, tachycardia and palpitation.

Central Nervous System:   Psychotic episodes have been rarely reported at recommended doses. Dizziness, dysphoria, overstimulation, euphoria, insomnia, tremor, restlessness and headache. Exacerbation of motor and phonic tics and Tourette's syndrome.

Gastrointestinal:   Diarrhea, constipation, dryness of mouth, unpleasant taste and other gastrointestinal disturbances.

Hypersensitivity:    Urticaria.

Endocrine:   Impotence and changes in libido.

Miscellaneous:    Suppression of growth has been reported with the long-term use of stimulants in children (see WARNINGS).

DRUG ABUSE AND DEPENDENCE

Controlled Substance:   DESOXYN tablets are subject to control under DEA schedule II.

Abuse:   Methamphetamine has been extensively abused. Tolerance, extreme psychological dependence, and severe social disability have occurred. There are reports of patients who have increased the dosage to many times that recommended. Abrupt cessation following prolonged high dosage administration results in extreme fatigue and mental depression; changes are also noted on the sleep EEG. Manifestations of chronic intoxication with methamphetamine include severe dermatoses, marked insomnia, irritability, hyperactivity, and personality changes. The most severe manifestation of chronic intoxication is psychosis often clinically indistinguishable from schizophrenia.

Insulin requirements in diabetes mellitus may be altered in association with the use of methamphetamine and the concomitant dietary regimen.

Methamphetamine may decrease the hypotensive effect of guanethidine .

DESOXYN should not be used concurrently with monoamine oxidase inhibitors (see CONTRAINDICATIONS ).

Concurrent administration of tricyclic antidepressants and indirect-acting sympathomimetic amines such as the amphetamines, should be closely supervised and dosage carefully adjusted.

Phenothiazines are reported in the literature to antagonize the CNS stimulant action of the amphetamines.